If you would like to earn credit, you must take the pre-test first by clicking here.

This activity was supported by educational grants from AbbVie Inc.; Celgene Corporation; and Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Recent Advances in the Treatment of Newly Diagnosed Multiple Myeloma

Josh Epworth, ARNP
Seattle Cancer Care Alliance

Edward Libby, MD
University of Washington

Watch as two experts in the field of multiple myeloma (MM) interpret data on current and novel treatments, discuss how to select initial therapy based on patient risk and in alignment with guidelines and best practices, and evaluate the use of minimal residual disease testing in patients with MM.


Download Slides


These activities, certified for CME/CE/CPE credit, are jointly provided by

Annenberg Logo Harborside Press Logo

in collaboration with

Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.